Skip to main content
OpenTrials
Completed

NCT Number: NCT06436963

Exploring the Application of Narrative Medicine Combined With Case-Based Learning in the Standardized Training of General Practice Residents

This was a prospective, longitudinal, single-center nonrandomized controlled study. A total of 36 first- and second-year general practice residents of Zhejiang University School of Medicine were voluntarily enrolled in the experimental group. The remaining 9 residents served as a control group. The experimental group received narrative medicine training combined with CBL training. The control group received normal CBL training. None of the participants had previously had any training in narrative medicine. Teaching evaluation scores were measured for all subjects at baseline and 1 year after the training.

Completed

Looking for future studies?

Notify Me

Key information

Age range

24 year–28 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310009, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • first- and second-year general practice residents of Zhejiang University School of Medicine

Exclusion criteria

  • third-year general practice residents of Zhejiang University School of Medicine

Treatment and study plan

narrative medicine training combined with CBL training

Behavioral

The experimental group received narrative medicine training combined with CBL training.

CBL training

Behavioral

The control group received normal CBL training.

Primary outcomes

  1. Satisfaction Survey of Residents in the Experimental Group

    Time frame: 12 months

    The satisfaction survey was divided into five levels, ranging from "strongly agree" to "strongly disagree". The higher percent of agree means better result.

  2. Comparison of the SEGUE scale scores Between the Experimental Group and the Control Group

    Time frame: 12 months

    The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.

  3. Comparison of the JSE-S scale scores Between the Experimental Group and the Control Group

    Time frame: 12 months

    The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.

  4. Comparison of the SEGUE scale in Different Grades Before and After Training in the Experimental Group

    Time frame: 12 months

    The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.

  5. Comparison of the JSE-S scale in Different Grades Before and After Training in the Experimental Group

    Time frame: 12 months

    The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Registry information

Official study title

Narrative Medicine Combined With Case-Based Learning

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
May 31, 2024
Registry last updated
May 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.